Stay updated with breaking news from Receptor tyrosine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
–Multiple vepdegestrant studies enrolling globally, including Phase 1, 2, and 3 studies– – Preliminary data from the Phase 1b combination trial of vepdegestrant + palbociclib. | May 5, 2023 ....
Radiopharm Theranostics Ltd (ASX:RAD) has strengthened its advisory credentials with the appointment of Dr Susann Brady-Kalnay PhD to its Scientific. ....